BridgeMD
New treatment option for Stroke
Official title Combined Exercise and Targeted Therapy for Post-Stroke Reading Deficits
ClinicalTrials.gov ID: NCT06213272
What this study is testing
- What it's testing
- The goal of the proposed project is to test the effectiveness of a novel hybrid approach to treatment of reading disorders after stroke, in which exercise training will be used in combination with a targeted reading treatment. This approach is expected to increase cerebral circulation and help to rebuild and strengthen the damaged phonological neural networks.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85
You may be able to join if
- fluent and literate in English prior to stroke
- 1st ever stroke
- more than 3 months post-stroke
- post-stroke reading deficits, defined as reading aloud accuracy \<83% for single words or \<65% for readable nonwords
- living within a 50-mile radius from Kessler Foundation.
You likely can't join if
- contraindication to MRI
- prior neurological disease
- developmental learning or reading disability (i.e., developmental dyslexia)
- contraindication to exercise
- concurrent speech and language therapy
The study team makes the final eligibility decision.
Where it's taking place
- West Orange, New Jersey, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include West Orange, New Jersey, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.